Search

Showing "11155" results for ""

Small number of UK HIV-positive patients at risk of exhausting treatment options

Pilot study suggests that Kaletra maintenance therapy safe

European consensus meeting draws up guidelines on HIV and hepatitis treatment

AIDS events with a viral cause decline most steeply after starting HAART

Denying HIV treatment to failed asylum seekers makes no economic, public health or moral sense, say leading UK HIV doctors

HAART can be safely interrupted for over a year by patients with lowest ever CD4 cell count above 250 and a sustained treatment CD4 cell count of 500 or more

Report suggests short course of rifampicin/isoniazid as effective as standard course of isoniazid for the treatment of latent TB

Coinfection with hepatitis G has no benefit, finds study conducted amongst African women with HIV-1 and HIV-2

Mental health services at UK's largest HIV clinic face massive cuts

Thai tenofovir trial runs into trouble after ethics protests from drug users

Hepatitis C virus coinfection does not lead to faster HIV disease progression in US women's study

Stavudine and efavirenz in short supply for developing world, say manufacturers

Histoplasmosis common and severe even after HAART became available in Panama

Heterosexual transmission of HIV within UK still relatively rare: majority of cases of UK transmission involve gay men

Laboratory requirements for scaling up HIV treatment

Seroreversion possible, but rare, after early treatment of acute HIV infection

Two cases of occupational HIV transmission occur despite prompt PEP

First randomised study of treatment in primary HIV infection begins recruitment

Receive the latest HIV research and conference news

Showing "11155" results for ""

Small number of UK HIV-positive patients at risk of exhausting treatment options

Pilot study suggests that Kaletra maintenance therapy safe

European consensus meeting draws up guidelines on HIV and hepatitis treatment

AIDS events with a viral cause decline most steeply after starting HAART

Denying HIV treatment to failed asylum seekers makes no economic, public health or moral sense, say leading UK HIV doctors

HAART can be safely interrupted for over a year by patients with lowest ever CD4 cell count above 250 and a sustained treatment CD4 cell count of 500 or more

Report suggests short course of rifampicin/isoniazid as effective as standard course of isoniazid for the treatment of latent TB

Coinfection with hepatitis G has no benefit, finds study conducted amongst African women with HIV-1 and HIV-2

Mental health services at UK's largest HIV clinic face massive cuts

Thai tenofovir trial runs into trouble after ethics protests from drug users

Hepatitis C virus coinfection does not lead to faster HIV disease progression in US women's study

Stavudine and efavirenz in short supply for developing world, say manufacturers

Histoplasmosis common and severe even after HAART became available in Panama

Heterosexual transmission of HIV within UK still relatively rare: majority of cases of UK transmission involve gay men

Laboratory requirements for scaling up HIV treatment

Seroreversion possible, but rare, after early treatment of acute HIV infection

Two cases of occupational HIV transmission occur despite prompt PEP

First randomised study of treatment in primary HIV infection begins recruitment

Receive the latest HIV research and conference news